EP2076530A4 - Aus vögeln gewonnenes erythropoietin - Google Patents

Aus vögeln gewonnenes erythropoietin

Info

Publication number
EP2076530A4
EP2076530A4 EP07839423A EP07839423A EP2076530A4 EP 2076530 A4 EP2076530 A4 EP 2076530A4 EP 07839423 A EP07839423 A EP 07839423A EP 07839423 A EP07839423 A EP 07839423A EP 2076530 A4 EP2076530 A4 EP 2076530A4
Authority
EP
European Patent Office
Prior art keywords
erythropoietine
birds
derived
erythropoietine derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP07839423A
Other languages
English (en)
French (fr)
Other versions
EP2076530A1 (de
Inventor
Robert D Ivarie
Guodong Liu
Jeffrey C Rapp
Julie A Morris
Alex J Harvey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Georgia
University of Georgia Research Foundation Inc
Synageva Biopharma Corp
Original Assignee
University of Georgia
University of Georgia Research Foundation Inc
Synageva Biopharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Georgia, University of Georgia Research Foundation Inc, Synageva Biopharma Corp filed Critical University of Georgia
Publication of EP2076530A1 publication Critical patent/EP2076530A1/de
Publication of EP2076530A4 publication Critical patent/EP2076530A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/465—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from birds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/505—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP07839423A 2006-11-09 2007-10-10 Aus vögeln gewonnenes erythropoietin Withdrawn EP2076530A4 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US85789606P 2006-11-09 2006-11-09
US87760106P 2006-12-28 2006-12-28
US91850407P 2007-03-16 2007-03-16
PCT/US2007/021643 WO2008057161A1 (en) 2006-11-09 2007-10-10 Avian derived erythropoietin

Publications (2)

Publication Number Publication Date
EP2076530A1 EP2076530A1 (de) 2009-07-08
EP2076530A4 true EP2076530A4 (de) 2010-04-07

Family

ID=39364811

Family Applications (1)

Application Number Title Priority Date Filing Date
EP07839423A Withdrawn EP2076530A4 (de) 2006-11-09 2007-10-10 Aus vögeln gewonnenes erythropoietin

Country Status (6)

Country Link
EP (1) EP2076530A4 (de)
JP (1) JP2010509327A (de)
KR (1) KR20090090328A (de)
AU (1) AU2007318209A1 (de)
CA (1) CA2668487A1 (de)
WO (1) WO2008057161A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101932231A (zh) * 2008-01-07 2010-12-29 辛那杰瓦生物制药股份有限公司 禽类的糖基化
EA022396B1 (ru) * 2009-09-23 2015-12-30 Ратиофарм Гмбх Способ очистки рекомбинантного эритропоэтина человека (epo), эритропоэтин, очищенный данным способом, и фармацевтические композиции, содержащие такой эритропоэтин
US20140066379A1 (en) * 2012-08-30 2014-03-06 Body Organ Biomedical Corp. Recombinant vector, transgenic fish egg using the same and biomaterial using the same
JP6920280B2 (ja) * 2016-03-31 2021-08-18 株式会社カネカ 精製されたネコ由来エリスロポエチンの製造方法
US11155794B2 (en) * 2016-08-23 2021-10-26 Alexion Pharmaceuticals, Inc. Method of purifying a heterologous protein from an egg white

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004067713A2 (en) * 2003-01-24 2004-08-12 Avigenics Inc. Exogenous proteins expressed in avians and their eggs
WO2006112147A1 (ja) * 2005-03-30 2006-10-26 Kaneka Corporation エリスロポエチンを産生するトランスジェニック鳥類およびその作製法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE489461T1 (de) * 1997-10-16 2010-12-15 Univ Georgia Transgene vögel und proteinproduktion
US7129390B2 (en) * 1997-10-16 2006-10-31 Avigenics, Inc Poultry Derived Glycosylated Interferon Alpha 2b
DE69933216T2 (de) * 1998-06-15 2007-09-20 GTC Biotherapeutics, Inc., Framingham Erythropoietin-analog-menschliches serum-albumin fusionsprotein
ATE513038T1 (de) * 2001-09-18 2011-07-15 Synageva Biopharma Corp Produktion eines transgenen vogels mittels cytoplasmainjektion

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004067713A2 (en) * 2003-01-24 2004-08-12 Avigenics Inc. Exogenous proteins expressed in avians and their eggs
WO2006112147A1 (ja) * 2005-03-30 2006-10-26 Kaneka Corporation エリスロポエチンを産生するトランスジェニック鳥類およびその作製法
US20090064351A1 (en) * 2005-03-30 2009-03-05 Kaneka Corporation Transgenic bird producing erythropoietin and method of constructing the same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2008057161A1 *

Also Published As

Publication number Publication date
AU2007318209A1 (en) 2008-05-15
JP2010509327A (ja) 2010-03-25
WO2008057161A1 (en) 2008-05-15
CA2668487A1 (en) 2008-05-15
KR20090090328A (ko) 2009-08-25
EP2076530A1 (de) 2009-07-08

Similar Documents

Publication Publication Date Title
EP2087096A4 (de) Modifizierte cyanobakterien
DE602006019782D1 (de) Kapselperforationsmodul
EP1984575A4 (de) Verschleissanordnung
AT504580A3 (de) Scan-einrichtung
DE602007012130D1 (de) Modifizierte flavin-adenin-dinucleotid-abhängige glucose-dehydrogenase
DE602007006947D1 (de) Pyridopyrimidinonderivate
DE602007009337D1 (de) Tastfeedbackvorrichtung
DE602007000274D1 (de) Mähdrescher
DE502007001629D1 (de) Rfahren
DE602006020192D1 (de) Riemenscheibenanorndung
BRPI0717939A2 (pt) Aminometil-4-imidazóis
BRPI0720224A2 (pt) Arilpirazóis substituídos
DE502007002453D1 (de) Kunstoffverdichtergehäuse
DE502007000361D1 (de) Stanznieteinheit
DE602006019150D1 (de) Riemenscheibenanorndung
DE602007000058D1 (de) Abdeckeinrichtung
AT504146A3 (de) Vogelschutzvorrichtung
DE502007001652D1 (de) Notöltank
EP2054074A4 (de) Modifiziertes erythropoietin
DE502007006319D1 (de) Staubabsaugadaptervorrichtung
DE602006016174D1 (de) Blisterverpackungsverfahren
BRPI0719956A2 (pt) Radiofluoração
DE102006045567A8 (de) Crimpstabilisierung
FI7587U1 (fi) Vetovoimamittalaite
PT2062053E (pt) Métodos de imunoensaio melhorados

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20090331

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

RIN1 Information on inventor provided before grant (corrected)

Inventor name: MORRIS, JULIE A.

Inventor name: RAPP, JEFFREY C.

Inventor name: LIU, GUODONG

Inventor name: HARVEY, ALEX J.

Inventor name: IVARIE, ROBERT D.

A4 Supplementary search report drawn up and despatched

Effective date: 20100310

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20090911

R18D Application deemed to be withdrawn (corrected)

Effective date: 20100609